scholarly journals Specific Treatment of Bone Metastases in Non-PC Urological Malignancies

2019 ◽  
Vol 1 (2) ◽  
Author(s):  
Aleksandar Vuksanovic
Bone Cancer ◽  
2015 ◽  
pp. 537-556
Author(s):  
Nathan Lawrentschuk ◽  
Nieroshan Rajarubendra ◽  
Damien Bolton

2022 ◽  
pp. 827-849
Author(s):  
Sean Ong ◽  
Dominic Bagguley ◽  
Neiroshan Rajarubendra ◽  
Nathan Lawrentschuk

2019 ◽  
Vol 47 (1) ◽  
pp. 178-184 ◽  
Author(s):  
Ilhan Lim ◽  
Maria Liza Lindenberg ◽  
Esther Mena ◽  
Nicholas Verdini ◽  
Joanna H. Shih ◽  
...  

Abstract Purpose We evaluated the prognostic value of 18F-sodium fluoride (NaF) PET/CT in patients with urological malignancies treated with cabozantinib and nivolumab with or without ipilimumab. Methods We prospectively recruited patients with advanced urological malignancies into a phase I trial of cabozantinib plus nivolumab with or without ipilimumab. NaF PET/CT scans were performed pre- and 8 weeks post-treatment. We measured the total volume of fluoride avid bone (FTV) using a standardized uptake value (SUV) threshold of 10. We used Kaplan-Meier analysis to predict the overall survival (OS) of patients in terms of SUVmax, FTV, total lesion fluoride (TLF) uptake at baseline and 8 weeks post-treatment, and percent change in FTV and TLF. Result Of 111 patients who underwent NaF PET/CT, 30 had bone metastases at baseline. Four of the 30 patients survived for the duration of the study period. OS ranged from 0.23 to 34 months (m) (median 6.0 m). The baseline FTV of all 30 patients ranged from 9.6 to 1570 ml (median 439 ml). The FTV 8 weeks post-treatment was 56–6296 ml (median 448 ml) from 19 available patients. Patients with higher TLF at baseline had shorter OS than patients with lower TLF (3.4 vs 14 m; p = 0.022). Patients with higher SUVmax at follow-up had shorter OS than patients with lower SUVmax (5.6 vs 24 m; p = 0.010). However, FTV and TLF 8 weeks post-treatment did not show a significant difference between groups (5.6 vs 17 m; p = 0.49), and the percent changes in FTV (12 vs 14 m; p = 0.49) and TLF (5.6 vs 17 m; p = 0.54) also were not significant. Conclusion Higher TLF at baseline and higher SUVmax at follow-up NaF PET/CT corresponded with shorter survival in patients with bone metastases from urological malignancies who underwent treatment. NaF PET/CT may be a useful predictor of OS in this population.


Urology ◽  
2010 ◽  
Vol 76 (4) ◽  
pp. 782-790 ◽  
Author(s):  
Nieroshan Rajarubendra ◽  
Damien Bolton ◽  
Nathan Lawrentschuk

Author(s):  
Charlotte Jaite ◽  
Betteke Maria van Noort ◽  
Timo D. Vloet ◽  
Erika Graf ◽  
Viola Kappel ◽  
...  

Abstract. Objective: We examined predictors and moderators of treatment outcome in mothers and children diagnosed with ADHD in a large multicentre RCT. Method: In total, 144 mother-child dyads with ADHD were randomly assigned to either a maternal ADHD treatment (group psychotherapy and open methylphenidate medication, TG) or to a control treatment (individual counselling without psycho- or pharmacotherapy, CG). After maternal ADHD treatment, parent-child training (PCT) for all mother-child dyads was added. The final analysis set was based on 123 dyads with completed primary outcome assessments (TG: n = 67, CG: n = 56). The primary outcome was the change in each child’s externalizing symptoms. Multiple linear regression analyses were performed. Results: The severity of the child’s externalizing problem behaviour in the family at baseline predicted more externalizing symptoms in the child after PCT, independent of maternal treatment. When mothers had a comorbid depression, TG children showed more externalizing symptoms after PCT than CG children of depressive mothers. No differences between the treatment arms were seen in the mothers without comorbid depression. Conclusions: Severely impaired mothers with ADHD and depressive disorder are likely to need additional disorder-specific treatment for their comorbid psychiatric disorders to effectively transfer the contents of the PCT to the home situation (CCTISRCTN73911400).


1986 ◽  
Vol 31 (11) ◽  
pp. 897-898
Author(s):  
Louis B. Schlesinger

2000 ◽  
Author(s):  
K. D. O'Leary ◽  
R. E. Heyman ◽  
P. H. Neidig

Sign in / Sign up

Export Citation Format

Share Document